Nuance DAX Copilot
Microsoft for Healthcare brings Dragon Copilot, Dragon Medical One, and PowerMic Mobile to clinicians, combining speech recognition and an AI clinical assistant to streamline documentation and clinical tasks.

Insilico Medicine is a clinical-stage biotechnology company that uses generative AI to discover and develop drugs, offering a suite of tools for target discovery, molecule generation, and clinical trial prediction.
Insilico Medicine is a clinical-stage biotechnology company that applies generative artificial intelligence to drug discovery and development, aiming to extend healthy productive longevity. Its Pharma.AI platform provides a suite of tools that span target identification, molecule generation, and clinical trial prediction, serving researchers and pharmaceutical teams seeking to reduce the time and cost of bringing new therapies to patients.
PandaOmics drives the discovery and prioritization of novel drug targets by analyzing multiomics data. It supports disease modeling and target identification, helping researchers uncover biological pathways that could lead to new treatments. The platform integrates with other components of Pharma.AI, enabling a seamless flow from target hypothesis to experimental validation.
Chemistry42 generates novel molecules with desired properties. It includes Alchemistry, a physics-based relative binding free energy engine that evaluates molecular interactions. ADMET and off-target predictions allow on-the-fly optimization, while MDFlow provides end-to-end simulation workflows. Retrosynthesis predicts synthetic routes for molecular structures, and MolSpace visualizes generated results using generative topographic mapping for comparison with public data. Nach01, a multimodal natural and chemical languages foundation model, further enhances molecular design capabilities.
inClinico is designed to predict clinical trial outcomes and assist in trial design. By analyzing historical trial data and biological insights, it helps researchers prioritize candidates and optimize protocols, potentially increasing the probability of success in later stages. This tool complements the preclinical discovery process, offering a bridge to clinical development.
The Precious series of models focuses on aging and longevity. Precious1GPT predicts biological age and identifies targets from multiomics data. Precious2GPT synthesizes multimodal multiomics data, while Precious3GPT serves as a multi-tissue, multispecies, multiomics, multimodal life model. The Virtual Aging Cell is a multi-agent virtual cell that uses biological age as a core condition, enabling simulations of aging processes and interventions.
DORA is a multi-agent generative research assistant that supports scientific inquiry. Life Star 2 provides an automated lab operating environment, streamlining experimental workflows. The Data Warehouse ensures cross-application data flow through efficient integration and standardization. Additionally, MCPs (Model Context Protocol servers) expose Pharma.AI tools to agents, and Skills + Agents offer agentic workflows built on the Pharma.AI stack.
PSI Frontier offers resources for model evaluation and development. Science MMAI Gym boosts foundation model intelligence in drug discovery, while Models provides frontier state-of-the-art models for pharma. DDD Benchmark evaluates model capability across the drug discovery and development process, and ScienceAI Bench assesses broader scientific reasoning across biology, chemistry, and longevity. These tools support the training and benchmarking of AI models, fostering transparency and progress in the field.
Insilico Medicine also applies generative AI technologies to environmental sustainability, exploring ways to address ecological challenges through computational approaches. This initiative reflects the company's broader mission to leverage AI for societal benefit beyond human health.
Insilico Medicine's platform is grounded in peer-reviewed research and a clinical pipeline that includes Rentosertib, a drug candidate currently in Phase III trials for idiopathic pulmonary fibrosis. The company's integrated approach aims to transform drug discovery by combining generative AI with automation and multiomics analysis, offering a comprehensive toolkit for researchers and pharmaceutical partners.
Subscription pricing is not listed.
Features, pricing and availability may change. Always verify details on the official website. Maintained by steven · Last updated Oct 16, 2026 →
Microsoft for Healthcare brings Dragon Copilot, Dragon Medical One, and PowerMic Mobile to clinicians, combining speech recognition and an AI clinical assistant to streamline documentation and clinical tasks.
Notable is a healthcare automation platform that deploys AI agents across patient access, revenue cycle, care operations, and contact center work. It is built for health systems, health plans, and provider organizations that want to reduce administrative load without adding staff.
IQVIA provides life sciences organizations with data, analytics, and technology to accelerate innovation, improve patient outcomes, and bring treatments to market faster.
Tempus is a precision medicine platform that combines genomic testing and clinical data with AI to support oncology, cardiology, neurology, and psychiatry care and research.